πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8084417

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080565

Substituted 4-amino-benzylpiperidine compounds

Theravance, Inc. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080572

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067439

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8053448

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044195

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044045

Indazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039489

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034946

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030502

Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

Theravance, Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030445

Glycopeptide derivative

Theravance, Inc. Β· Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017617

Amidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017783

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8013152

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8013005

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008278

Diarylmethyl and related compounds

Theravance, Inc. Β· Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003664

Indazole-carboxamide compounds

Theravance, Inc. Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003755

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994165

Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994209

3-phenoxymethylpyrrolidine compounds

Theravance, Inc. Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7989484

Dual-acting antihypertensive agents

Theravance, Inc. Β· Granted Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7981931

Pharmaceutical compositions of short-acting sedative hypnotic agent

Theravance, Inc. Β· Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964730

Amino-substituted ethylamino Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960385

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted